NoMore(R) Expands Global Distribution and Unveils Patented Next-Gen Device with Companion App
VICENZA, IT / ACCESS Newswire / December 3, 2025 /NoMore announced today it is accelerating global distribution of its NoMore Colds red-light therapy device while revealing plans for a patented next-generation product that will launch alongside a companion app designed to track user progress and offer optional clinician oversight. The move comes as the wellness technology market continues its rapid expansion, with recent data from Grand View Research showing the global wellness tech sector is expected to reach $275 billion by 2028.
The Italy-based company, which has moved over 50,000 units globally since launching in 2023, is now strengthening its distribution infrastructure in non-EU markets while upgrading customer support touchpoints and product quality standards. The timing is significant, as consumer interest in drug-free wellness solutions reaches new highs across North America and the UK.
Market Positioning in a Crowded Wellness Space
The announcement positions NoMore strategically within the expanding wellness technology sector. According to McKinsey 's latest consumer health report, nearly 80% of consumers now prioritize wellness in their daily routines, creating substantial demand for alternatives to traditional pharmaceutical approaches. "We 've been working toward this for over a year because the market needed something that fits into daily life without the medication cycle, " said Rick and Nick, Co-Founders and Co-CEOs of NoMore.
The company 's flagship NoMore Colds device uses red-light photobiomodulation technology in a 10-minute daily routine format. It 's designed for adults dealing with frequent congestion, sinus issues, or nighttime stuffiness-a market segment that research from the Asthma and Allergy Foundation estimates affects over 50 million Americans annually.
The patented next-generation product represents a significant strategic shift for the company.
App Integration Signals Industry Trend
The upcoming NoMore companion app will track personal progress metrics, offer optional access to clinicians for guidance, and provide exclusive discounts for community members. This approach mirrors a broader industry pattern that has been building momentum. Deloitte 's 2025 health tech outlook found that integrated wellness platforms with personalized tracking show 40% higher user retention compared to standalone devices-a significant advantage in an increasingly competitive landscape.
"This isn 't just another product launch-it 's our answer to what we 've been hearing from customers for months, " explained Rick and Nick. "People want to see their progress. They want the option to connect with a doctor if they need guidance. And they want to feel like they 're part of something bigger than just buying a device. "
The company has opened a limited early-access beta list for non-EU markets, with staged rollouts planned based on regulatory timelines and operational capacity. In the wellness device space, which has become increasingly crowded, companies that offer integrated experiences tend to capture more market share.
Operational Upgrades Support Growth Trajectory
Beyond the product announcements, NoMore has enhanced packaging integrity, clarified user instructions, and improved onboarding processes to support growing international demand. The company has also reinforced its post-purchase support infrastructure, including 30-day money-back guarantees and one-year warranty handling-critical elements when scaling globally while maintaining quality standards.
The strategy appears sound when examining market data. The global market for non-invasive wellness devices has seen consistent growth, with Allied Market Research projecting compound annual growth rates of 6.8% through 2030. NoMore 's focus on non-EU markets-particularly the US, UK, and Canada-targets regions where consumer spending on wellness tech remains strongest.
"What we 're seeing is that people are tired of cycling through sprays and medications that don 't address underlying comfort issues, " noted Rick and Nick. "The data shows there 's genuine appetite for science-backed alternatives that fit into daily routines, which is exactly why we decided to expand distribution while simultaneously developing the next generation. "
The company maintains its safety-first approach, recommending doctor consultation for pregnant or breastfeeding individuals, those on medications, or people with existing medical conditions. This wellness-oriented messaging-rather than medical claims-aligns with regulatory requirements while still addressing consumer needs.
What This Means for the Wellness Tech Space
The announcement positions NoMore to compete more directly with established players in the breathing wellness category. However, the company 's combination of portability (the device weighs just 12 grams), app integration, and potential clinical oversight creates a differentiated value proposition in this space.
Industry analysts suggest moves like this typically signal broader shifts in how consumers approach everyday health maintenance. The integration of technology, professional guidance, and habit-forming routines represents where wellness products are heading-away from one-time purchases and toward ongoing engagement models. While not a new trend, it is one that 's accelerating.
"It 's all about making clearer breathing a simple, repeatable habit-something the market has been asking for but hasn 't received in this format, " said Rick and Nick.
The company plans to maintain its direct-to-consumer sales model while selectively activating channel partners in key markets. With the patented innovation still in staged development and the app in beta testing, NoMore appears positioned for significant growth over the next 18-24 months.
Whether the expanded distribution and new product line can capture meaningful market share remains to be seen. However, in a wellness sector increasingly defined by integrated experiences and personalized solutions, NoMore 's approach aligns with several current market trends. Execution will matter more than strategy-many companies announce ambitious plans but struggle with actual rollout, especially when dealing with regulatory requirements across multiple markets.
About NoMore
NoMore, founded in 2023 and headquartered in Vicenza, Italy, develops a line of non-invasive, drug-free red-light therapy devices. The company serves customers globally through direct-to-consumer channels and selective B2B partnerships, focusing on portable, habit-friendly wellness solutions backed by photobiomodulation research.
Media Contact:
NoMore
Riccardo P. & Nicolò F. Co-Founders and Co-CEOs
support@try-nomore.com
Website: https://try-nomore.com
City: Vicenza
Country: Italy
SOURCE:NoMore
View the original press release on ACCESS Newswire
© 2025 ACCESS Newswire. All Rights Reserved.













